TTEC Holdings, Inc.recently hosted a grand opening of its Oklahoma City facility.
The sickle cell pain drug, Adakveo, was researched and created in Oklahoma City. Several entities at the Innovation District were involved in the work, including the Oklahoma Medical Research Foundation and Cytovance Biologics.
This is the first time the conference has been held in Oklahoma City. The expo is one of the largest of its kind and brings in sports-event organizers from all over the world.
Estimates put total public and private investment so far into Oklahoma City’s downtown area since 1993 at nearly $7 billion.
The unemployment rate in the Greater Oklahoma City MSA fell to 2.9% for the month of September, according to the Bureau of Labor Statistics.
Public investment through the MAPS program has triggered substantial private sector investment.
Experts agree that the key to continuing this sector’s growth remains the availability of a qualified workforce.
The MAPS 4 proposal includes a number of projects intended to promote community and collaboration in an area where health, energy, aerospace, technology and research companies rub elbows.